Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.
Bungie's latest FPS and the return of the OG deckbuilding roguelite are this week's PC standouts, but there are many ...
The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results